Morphologic and Functional Assessment of Field-Potentiated Optic Nerve Regeneration
Project Number5R01EY035715-02
Contact PI/Project LeaderGOKOFFSKI, KIMBERLY K
Awardee OrganizationUNIVERSITY OF SOUTHERN CALIFORNIA
Description
Abstract Text
Project Summary
To date, no therapy exists to restore vision to the over 64 million people worldwide who are legally blind from
diseases that damage the optic nerve. Neuro-protective strategies aimed at preventing damaged retinal ganglion cells
(RGCs) from degenerating and neuro-regenerative strategies aimed at promoting axon growth confer modest gains in
vision after optic nerve crush injury when applied alone. Moreover, these approaches appear to be lacking in guidance
cues as regenerating RGC axons have been reported to have circuitous projections, with 10-20% of axons exhibiting
premature branching and 40% of axons having regenerated aberrantly, making u-turns and extending back towards the eye
or growing into the opposite optic nerve. We have shown that exogenously applied electric fields (EFs) not only
promote RGC axon growth but appear to also be able to control the direction of axon growth. This suggests that EFs
may be exploited to not only “drive” axon growth but also “steer” axons to grow towards intended targets. Indeed, in vivo
stimulation with asymmetric waveforms was found to be effective at directing full-length optic nerve regeneration,
without evidence of aberrant targeting, and restoring partial visual function (local field potential recordings in the superior
colliculus and pattern electroretinogram) after crush injury. Given this, we hypothesized that combining EF
stimulation with other neuro-regenerative strategies would have synergistic effects on promoting optic nerve
regeneration. More targeted regeneration could confer increased gains in visual function. Our multi-disciplinary
consortium between neuro-ophthalmologists, developmental biologists, neuro-anatomists, neurosurgeons,
electrophysiologists, and electrical engineers proposes to test the efficacy of combining neuro-protective and neuro-
regenerative strategies with EF application to direct RGC axon regeneration and restore visual function to adult rats after
optic nerve crush injury. Additionally, we will map and characterize the morphology and trajectory of regenerated axons
in whole rat brains using 3D light sheet microscopy and SHIELD tissue clearing histology and assess whether EFs direct
target specific regeneration.
Public Health Relevance Statement
Current neuro-protective and neuro-regenerative strategies to restore vision to the over 64 million
people worldwide who are legally blind from diseases that damage the optic nerve are successful at
promoting survival of damaged retinal ganglion cells (RGCs) and promoting long distance RGC axon
regeneration but are lacking in cues to guide axons towards appropriate targets in the brain. We have
shown that exogenously applied electric fields (EFs) not only promote RGC axon growth but appear to
also be able to control the direction of axon growth. In this project, we propose to develop EF
application into a technology that will synergize that with current strategies for optic nerve regeneration
by providing directional cues for regenerating axons, leading to more targeted growth and increased
recovery of visual function.
No Sub Projects information available for 5R01EY035715-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EY035715-02
Patents
No Patents information available for 5R01EY035715-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EY035715-02
Clinical Studies
No Clinical Studies information available for 5R01EY035715-02
News and More
Related News Releases
No news release information available for 5R01EY035715-02
History
No Historical information available for 5R01EY035715-02
Similar Projects
No Similar Projects information available for 5R01EY035715-02